734 related articles for article (PubMed ID: 15670659)
1. Role of fatty liver, dietary fatty acid supplements, and obesity in the progression of alcoholic liver disease: introduction and summary of the symposium.
Purohit V; Russo D; Coates PM
Alcohol; 2004 Aug; 34(1):3-8. PubMed ID: 15670659
[TBL] [Abstract][Full Text] [Related]
2. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis.
Lieber CS
Alcohol; 2004 Aug; 34(1):9-19. PubMed ID: 15670660
[TBL] [Abstract][Full Text] [Related]
3. Role of iron in alcoholic liver disease: introduction and summary of the symposium.
Purohit V; Russo D; Salin M
Alcohol; 2003 Jun; 30(2):93-7. PubMed ID: 12957291
[TBL] [Abstract][Full Text] [Related]
4. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
5. Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis.
Nagata K; Suzuki H; Sakaguchi S
J Toxicol Sci; 2007 Dec; 32(5):453-68. PubMed ID: 18198478
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of alcoholic liver disease: role of oxidative metabolism.
Ceni E; Mello T; Galli A
World J Gastroenterol; 2014 Dec; 20(47):17756-72. PubMed ID: 25548474
[TBL] [Abstract][Full Text] [Related]
7. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M
Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318
[TBL] [Abstract][Full Text] [Related]
8. Translational Implications of the Alcohol-Metabolizing Enzymes, Including Cytochrome P450-2E1, in Alcoholic and Nonalcoholic Liver Disease.
Song BJ; Akbar M; Jo I; Hardwick JP; Abdelmegeed MA
Adv Pharmacol; 2015; 74():303-72. PubMed ID: 26233911
[TBL] [Abstract][Full Text] [Related]
9. Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis.
Reeves HL; Burt AD; Wood S; Day CP
J Hepatol; 1996 Nov; 25(5):677-83. PubMed ID: 8938545
[TBL] [Abstract][Full Text] [Related]
10. Role of oxidative stress and antioxidant therapy in alcoholic and nonalcoholic liver diseases.
Lieber CS
Adv Pharmacol; 1997; 38():601-28. PubMed ID: 8895826
[TBL] [Abstract][Full Text] [Related]
11. The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis.
Sozio MS; Liangpunsakul S; Crabb D
Semin Liver Dis; 2010 Nov; 30(4):378-90. PubMed ID: 20960377
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of Alcoholic Fatty Liver a Narrative Review.
Seitz HK; Moreira B; Neuman MG
Life (Basel); 2023 Jul; 13(8):. PubMed ID: 37629519
[TBL] [Abstract][Full Text] [Related]
13. An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice.
Mandrekar P; Ambade A; Lim A; Szabo G; Catalano D
Hepatology; 2011 Dec; 54(6):2185-97. PubMed ID: 21826694
[TBL] [Abstract][Full Text] [Related]
14. Role of S-adenosyl-L-methionine in the treatment of alcoholic liver disease: introduction and summary of the symposium.
Purohit V; Russo D
Alcohol; 2002 Jul; 27(3):151-4. PubMed ID: 12163142
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of alcoholic fatty liver.
Purohit V; Gao B; Song BJ
Alcohol Clin Exp Res; 2009 Feb; 33(2):191-205. PubMed ID: 19032584
[TBL] [Abstract][Full Text] [Related]
16. Non-Alcoholic Fatty Liver Disease.
Engin A
Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
[TBL] [Abstract][Full Text] [Related]
17. Etiopathogenesis of nonalcoholic steatohepatitis.
Chitturi S; Farrell GC
Semin Liver Dis; 2001; 21(1):27-41. PubMed ID: 11296694
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of alcohol-associated cancers: introduction and summary of the symposium.
Purohit V; Khalsa J; Serrano J
Alcohol; 2005 Apr; 35(3):155-60. PubMed ID: 16054976
[TBL] [Abstract][Full Text] [Related]
19. Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium.
Purohit V; Abdelmalek MF; Barve S; Benevenga NJ; Halsted CH; Kaplowitz N; Kharbanda KK; Liu QY; Lu SC; McClain CJ; Swanson C; Zakhari S
Am J Clin Nutr; 2007 Jul; 86(1):14-24. PubMed ID: 17616758
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin and alcoholic fatty liver disease.
Rogers CQ; Ajmo JM; You M
IUBMB Life; 2008 Dec; 60(12):790-7. PubMed ID: 18709650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
